Pradelli, L., Calandriello, M., Di Virgilio, R., Bellone, M., & Tubaro, M. (2014). Cost‑effectiveness analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients. Farmeconomia. Health Economics and Therapeutic Pathways, 15(4), 101–112. https://doi.org/10.7175/fe.v15i4.971